Late-onset neutropenia following RCHOP chemotherapy in diffuse large B-cell lymphoma

Late-onset neutropenia following RCHOP chemotherapy in diffuse large B-cell lymphoma

10.1002/ajh.21420

Saved in:

Bibliographic Details
Main Authors:	Lai, G.G.Y., Lim, S.-T., Tao, M., Chan, A., Li, H., Quek, R.
Other Authors:	PHARMACY
Format:	Article
Published:	2014
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/106106
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

The Effect of CHOP or RCHOP Chemotherapy Regiment on D-dimer Levels of Non-Hodgkin Lymphoma Patients
by: Dewi A.K., et al.
Published: (2019)

TARGETING DNA DAMAGE RESPONSE KINASES TO IMPROVE CHEMOTHERAPY EFFICACY IN DIFFUSE LARGE B-CELL LYMPHOMA
by: ALLISON SI-YU CHAN
Published: (2023)

Primary response and saefty of 90yitrium ibritumomab tiuxetan followed by combined chemotherapy of cyclophosphamide, doxorubicin, vincristine, and prednisolone for diffuse large B-Cell lymphoma
by: Krittika Tanyasaensook
Published: (2010)

Prospective audit of post-chemotherapy febrile neutropenia in patients with solid cancer and lymphoma in two Singaporean cancer centres
by: Wong, M., et al.
Published: (2016)

Transient adrenal insufficiency in diffuse large B cell lymphoma patients after chemotherapy with short-course, high-dose corticosteroids
by: Weerapat Owattanapanich, et al.
Published: (2019)

The reliability of FEbrile Neutropenia after ChEmotherapy (FENCE) scores in predicting granulocyte colony-stimulating factor breakthrough febrile neutropenia among patients with lymphoma undergoing first-cycle chemotherapy: A prospective observational study
by: Thungthong P.
Published: (2023)

Comparison of daily filgrastim and pegfilgrastim to prevent febrile neutropenia in Asian lymphoma patients
by: Chan, A., et al.
Published: (2014)

Breakthrough febrile neutropenia and associated complications among elderly cancer patients receiving myelosuppressive chemotherapy for solid tumors and lymphomas
by: Chan, A., et al.
Published: (2014)

Plasma Factors for the Differentiation of Hodgkin's Lymphoma and Diffused Large B Cell Lymphoma and for Monitoring Remission.
by: Zeng, Qun, et al.
Published: (2023)

Anterior panhypopituitarism in diffuse large B-cell stage IV lymphoma
by: Valeros, K.A., et al.
Published: (2016)

The incidence and risk factors of severe neutropenia and febrile neutropenia due to chemotherapy among gynecologic cancer patients in Thailand
by: P. Pimsi, et al.
Published: (2019)

Utilization of pathway signatures to reveal distinct types of B lymphoma in the Eμ-myc model and human diffuse large B-cell lymphoma
by: Mori, S., et al.
Published: (2014)

Febrile neutropenia after chemotherapy in patients with non-hematologic malignancies
by: Narin Voravud, et al.
Published: (2006)

Angiocentric T-cell lymphoma of the pancreas presenting as late-onset diabetes mellitus with diabetic retinopathy
by: Sanya Sukpanichnant, et al.
Published: (2018)

Routine primary prophylaxis for febrile neutropenia with biosimilar granulocyte colony-stimulating factor (nivestim) or pegfilgrastim is cost effective in non-Hodgkin lymphoma patients undergoing curative-intent R-CHOP chemotherapy
by: Wang X.J., et al.
Published: (2018)

Breakthrough febrile neutropenia and associated complications in non-Hodgkin's lymphoma patients receiving pegfilgrastim
by: Ng, J.H., et al.
Published: (2014)

Modulators of rituximab-induced complement-dependent cytotoxicity in diffuse large B-cell lymphoma
by: Ong, Charmaine Zi Yan
Published: (2021)

Changes in etiologic microorganisms in Thai patients with chemotherapy-induced neutropenia and fever
by: Chonticha Auesomwang, et al.
Published: (2019)

F-18 FDG uptake in hemorrhoids in a patient with diffuse large B-cell lymphoma
by: Tanyaluck Thientunyakit, et al.
Published: (2018)

Combinatorial epigenetic therapy in diffuse large B cell lymphoma pre-clinical models and patients
by: Pera, B, et al.
Published: (2020)

The Contribution of MYC and PLK1 Expression to Proliferative Capacity in Diffuse Large B-Cell Lymphoma
by: Ming Liang Oon, et al.
Published: (2020)

Identification of molecular factors mediating therapeutic resistance in diffuse large B-cell lymphoma (DLBCL)
by: Peng, Chenchen
Published: (2024)

Ekspresi EBNA-1 pada diffuse large B cell lymphoma serta Small lymphocytic lymphoma tipe nodal dan ekstranodal
by: Perpustakaan UGM, i-lib
Published: (2006)

Costs associated with febrile neutropenia in solid tumor and lymphoma patients - An observational study in Singapore
by: Wang X.J., et al.
Published: (2018)

High-dose methotrexate is effective for prevention of isolated CNS relapse in diffuse large B cell lymphoma
by: Ong, Shin Yeu, et al.
Published: (2021)

Spatially-resolved transcriptomics reveal macrophage heterogeneity and prognostic significance in diffuse large B-cell lymphoma
by: Liu, Min, et al.
Published: (2024)

Late-onset intrascleral dissemination of Pseudomonas aeruginosa scleritis following pterygium excision
by: Somsanguan Ausayakhun, et al.
Published: (2019)

Visualizing clinical predictors of febrile neutropenia in Asian cancer patients receiving myelosuppressive chemotherapy
by: Chen, C., et al.
Published: (2014)

DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes
by: Kizhakeyil, Atish, et al.
Published: (2022)

GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma
by: Smedby K.E., et al.
Published: (2018)

Non-myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: A multicentre experience
by: Andrew R. Rezvani, et al.
Published: (2018)

A Clinico-Genotypic Prognostic Index for De Novo Composite Diffuse Large B-Cell Lymphoma Arising from Follicular Lymphoma in Asian patients treated in the Rituximab Era
by: Lim, R.M.H., et al.
Published: (2021)

HUBUNGAN RASIO NETROFIL LIMFOSIT DENGAN RESPON TERAPI PASIEN DIFFUSE LARGE B-CELL LYMPHOMA YANG MENJALANI KEMOTERAPI RCHOP Penelitian Analisis Observasional Kohort Retrospektif Periode Januari 2015 sampai dengan Juli 2018 Poli Onkologi Satu Atap Divisi Hematologi Onkologi Medik Departemen Penyakit Dalam RSUD Dr. Soetomo Surabaya
by: SHEILA NALIA, NIM011218026315
Published: (2018)

Endothelial activation and stress index as a prognostic factor of diffuse large B-cell lymphoma: the report from the nationwide multi-center Thai Lymphoma Study Group
by: Thanhakun R.
Published: (2023)

One patient, two uncommon B-cell neoplasms: Solitary plasmacytoma following complete remission from intravascular large B-cell lymphoma involving central nervous system
by: Lee, J, et al.
Published: (2020)

Incidence of febrile neutropenia among early-stage breast cancer patients receiving anthracycline-based chemotherapy
by: Chan, A., et al.
Published: (2014)

Association between Breast Cancer Polygenic Risk Score and Chemotherapy-Induced Febrile Neutropenia: Null Results
by: Ong, Seeu Si, et al.
Published: (2023)

Serotype distribution and incidence of invasive early onset and late onset group B streptococcal disease amongst infants in Singapore
by: Kam, Kai-Qian, et al.
Published: (2022)

Serotype distribution and incidence of invasive early onset and late onset group B streptococcal disease amongst infants in Singapore
by: Kam, Kai-Qian, et al.
Published: (2022)

EKSPRESI P53 DAN Ki 67 PADA DIFFUSE LARGE B CELL LYMPHOMA TIPE NODAL DAN EKSTRANODA
by: , Rodlijatul Machfudzoh, et al.
Published: (2012)